Polycystin-1L1 Inhibitors
Polycystin-1L1 inhibitors belong to a specialized class of chemical compounds that are designed to interact with the protein polycystin-1L1, an integral membrane protein that is a member of the polycystin protein family. Polycystins are known for their involvement in various cellular processes, including cell signaling pathways that regulate a diverse range of cellular functions. Polycystin-1L1, in particular, shares homology with polycystin-1, which is implicated in the biology of cellular structures like primary cilia, known for sensing mechanical stimuli and initiating a cascade of intracellular responses. The inhibitors of polycystin-1L1 are characterized by their ability to bind to this protein and modulate its function.
The development of polycystin-1L1 inhibitors requires an in-depth understanding of the protein's biochemistry, including its conformational dynamics, ligand-binding sites, and the downstream pathways it influences. Advances in biophysical techniques such as X-ray crystallography, cryo-electron microscopy, and nuclear magnetic resonance (NMR) spectroscopy have aided scientists in mapping the three-dimensional structure of polycystin-1L1, enabling the rational design of inhibitors. Chemical compounds in this class may vary widely in their structure, ranging from small molecules to more complex biologics, each designed to interact with the polycystin-1L1 protein in a unique manner. The specificity and selectivity of these inhibitors are of paramount importance, as they must be able to distinguish between polycystin-1L1 and other proteins within the polycystin family or unrelated proteins within the cellular milieu. To achieve this, a combination of computational modeling and empirical testing is often used to refine the inhibitors and enhance their interaction with polycystin-1L1, ensuring that they effectively modulate the protein's activity without off-target effects.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor. By inhibiting histone deacetylase, it leads to an increase in acetylated histones, which can alter gene expression. As histone acetylation can affect the transcription of various genes, including those involved in the regulation of cell signaling pathways, Trichostatin A could potentially decrease the functional activity of Polycystin-1L1 through changes in gene expression that indirectly affect its signaling pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a potent inhibitor of phosphatidylinositol 3-kinase (PI3K). By inhibiting PI3K, it suppresses the PI3K/Akt signaling pathway, which is involved in numerous cellular processes including proliferation and survival. Since Polycystin-1L1 is involved in signal transduction that could be affected by the status of PI3K/Akt pathway, LY294002 may indirectly inhibit the functional activity of Polycystin-1L1 by altering the pathway dynamics. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin specifically inhibits the mammalian target of rapamycin (mTOR), a key regulatory kinase in the mTOR signaling pathway. The mTOR pathway plays a role in cell growth and proliferation. Through the inhibition of mTOR, Rapamycin could reduce the activity of pathways that might indirectly modulate the function of Polycystin-1L1, given the kinase's broad regulatory roles. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $49.00 $124.00 $441.00 $828.00 | 4 | |
WZB117 is a glucose transporter 1 (GLUT1) inhibitor, which can decrease cellular glucose uptake. Reduced glucose availability affects energy metabolism and can influence signaling pathways related to cell growth and survival. As Polycystin-1L1 is involved in cellular signaling, perturbation of the energy status of the cell could indirectly diminish its functional activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a specific inhibitor of mitogen-activated protein kinase kinase (MEK), which acts upstream of extracellular signal-regulated kinases (ERK1/2) in the MAPK pathway. By inhibiting MEK, PD98059 can suppress the activation of ERK, potentially affecting downstream signaling events. If Polycystin-1L1 is functionally coupled to the MAPK pathway, its activity could be indirectly decreased by PD98059 through this mechanism. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a selective inhibitor of p38 MAP kinase. It disrupts the p38 MAPK signaling pathway, which is involved in inflammatory responses and cell differentiation. The inhibition of p38 MAPK can lead to altered cellular responses that may indirectly impact the activity of Polycystin-1L1 if it is linked to pathways involving p38 MAPK. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a potent inhibitor of the Rho-associated protein kinase (ROCK). By inhibiting ROCK, Y-27632 can affect the organization of the actin cytoskeleton, cell adhesion, and motility. Since Polycystin-1L1 has roles in cellular processes that might intersect with cytoskeletal dynamics, the inhibition of ROCK could lead to a decrease in Polycystin-1L1 activity indirectly by altering the mechanical forces within the cell. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2 and by extension, the MAPK/ERK pathway. By blocking MEK1/2, U0126 prevents the activation of ERK1/2, which may alter cellular processes such as proliferation, differentiation, and survival. The inhibition of this pathway could have an indirect effect on the activity of Polycystin-1L1 if it is involved in signaling pathways or cellular processes that are regulated by the MAPK/ERK pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of PI3K. By inhibiting PI3K, Wortmannin suppresses the PI3K/Akt pathway, which can lead to significant changes in cell survival and metabolism. If Polycystin-1L1's activity is modulated by the PI3K/Akt pathway, then Wortmannin could indirectly inhibit Polycystin-1L1 by altering the pathway's activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), which is part of the MAPK signaling cascade. | ||||||